Donald Mattison has had a distinguished career in medicine and public health. In 2012 he was concurrently appointed Chief Medical Officer and Senior Vice President of Risk Sciences International and Associate Director of the McLaughlin Centre for Population Health Risk Assessment at the University of Ottawa. In 2013 he was also appointed Medical Advisor to QuarterWatch: Monitoring FDA MedWatch Reports, Institute for Safe Medication Practices. From 2002 to 2012 he was Senior Advisor to the Director of the Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health. He has also been the Medical Director of the March of Dimes, Dean of the Graduate School of Public Health at the University of Pittsburgh, Director of Human Risk Assessment at the FDA National Center for Toxicological Research and on the faculty of the University of Arkansas for Medical Sciences, University of Pittsburgh, and Columbia University. During this time he has also served in the US Public Health Service, with deployments for medical and public health support.
In his research he has led drug development in pediatrics and obstetrics, including safety signal identification and evaluation. He has also led the development of methods in risk assessment for reproductive and developmental endpoints. Currently his research explores approaches to understand drug use, effectiveness, safety and risk-benefit communications, as well as environmental impacts on population health.
Dr. Mattison earned a BA (Chemistry and Mathematics) from Augsburg College (Minneapolis, MN), an MS (Chemistry) from the Massachusetts Institute of Technology (Cambridge, MA) and a MD from the College of Physicians and Surgeons, Columbia University (New York, NY). His clinical training in Obstetrics and Gynecology was at the Sloane Hospital for Women in the Columbia Presbyterian Medical Center in New York. His training in Pharmacology and Toxicology was at the National Institutes of Health, Bethesda, MD.
He has published more than 200 peer reviewed articles. In 1997, he was elected a Fellow of the American Association for the Advancement of Science, in 1999, a Fellow of the New York Academy of Medicine, in 2000 a member of the Institute of Medicine, in 2005 Distinguished Alumni of Augsburg College and in 2009 a Fellow of the Royal Society of Medicine.